Gilead Prices COVID-19 Drug At $2,340 Per Patient In Developed Nations

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the...